U.S. markets closed

Angion Biomedica Corp. (ANGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
14.06+0.06 (+0.43%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 5/14/2021
Current
Market Cap (intraday) 5
412.78M
Enterprise Value 3
434.70M
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
139.90
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
150.94
Enterprise Value/EBITDA 7
-7.95

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-17.39%
S&P500 52-Week Change 341.30%
52 Week High 326.30
52 Week Low 312.56
50-Day Moving Average 314.92
200-Day Moving Average 317.20

Share Statistics

Avg Vol (3 month) 3137.61k
Avg Vol (10 day) 348.01k
Shares Outstanding 529.48M
Implied Shares Outstanding 6N/A
Float 21.73M
% Held by Insiders 126.73%
% Held by Institutions 110.72%
Shares Short (Apr 29, 2021) 4339.03k
Short Ratio (Apr 29, 2021) 44.94
Short % of Float (Apr 29, 2021) 42.12%
Short % of Shares Outstanding (Apr 29, 2021) 41.15%
Shares Short (prior month Mar 30, 2021) 4341.38k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,917.19%

Management Effectiveness

Return on Assets (ttm)-116.52%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)2.88M
Revenue Per Share (ttm)0.19
Quarterly Revenue Growth (yoy)-34.10%
Gross Profit (ttm)-37.29M
EBITDA -55.12M
Net Income Avi to Common (ttm)-80.11M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)34.61M
Total Cash Per Share (mrq)1.17
Total Debt (mrq)85.04M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.39
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-22.89M
Levered Free Cash Flow (ttm)-27.03M